Potential effects of icariin, the Epimedium-derived bioactive compound in the treatment of COVID-19: a hypothesis.
Naunyn Schmiedebergs Arch Pharmacol. 2022 Sep;395(9):1019-1027. doi: 10.1007/s00210-022-02262-y. Epub 2022 Jun 3.
Naunyn Schmiedebergs Arch Pharmacol. 2022.
PMID: 35657423
Free PMC article.
Review.